Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine doses for postoperative analgesia after open liver cancer resection
ChiCTR2100043881Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: Postoperative pain scores and Postoperative oxycodone consumption. Started Feb 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100043881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043881.